Cargando…

Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia

BACKGROUND: Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disease characterized by multiple recurring clonal cytogenetic anomalies and is the most common leukemia in adults. Chromosomal abnormalities associated with CLL include trisomy 12 and IGH;BCL3 rearrangement [t(14;19)(q32;q13)]...

Descripción completa

Detalles Bibliográficos
Autores principales: Alpatov, Roman, Carstens, Billie, Harding, Kimberly, Jarrett, Carolyn, Balakhani, Sudabeh, Lincoln, Jessica, Brzeskiewicz, Peter, Guo, Yu, Ohene-Mobley, Alex, LeRoux, Jamie, McDaniel, Veronica, Meltesen, Lynne, Minka, Diane, Patel, Mahendra, Manavi, Cyrus, Swisshelm, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696310/
https://www.ncbi.nlm.nih.gov/pubmed/26719766
http://dx.doi.org/10.1186/s13039-015-0203-y
_version_ 1782407774133551104
author Alpatov, Roman
Carstens, Billie
Harding, Kimberly
Jarrett, Carolyn
Balakhani, Sudabeh
Lincoln, Jessica
Brzeskiewicz, Peter
Guo, Yu
Ohene-Mobley, Alex
LeRoux, Jamie
McDaniel, Veronica
Meltesen, Lynne
Minka, Diane
Patel, Mahendra
Manavi, Cyrus
Swisshelm, Karen
author_facet Alpatov, Roman
Carstens, Billie
Harding, Kimberly
Jarrett, Carolyn
Balakhani, Sudabeh
Lincoln, Jessica
Brzeskiewicz, Peter
Guo, Yu
Ohene-Mobley, Alex
LeRoux, Jamie
McDaniel, Veronica
Meltesen, Lynne
Minka, Diane
Patel, Mahendra
Manavi, Cyrus
Swisshelm, Karen
author_sort Alpatov, Roman
collection PubMed
description BACKGROUND: Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disease characterized by multiple recurring clonal cytogenetic anomalies and is the most common leukemia in adults. Chromosomal abnormalities associated with CLL include trisomy 12 and IGH;BCL3 rearrangement [t(14;19)(q32;q13)] that juxtaposes a proto-oncogenic gene BCL3 and an immunoglobulin heavy chain, a translocation that may be associated with shorter survival. In addition to the IGH;BCL3 rearrangement, other translocations involving 14q32 locus are involved in various lymphoproliferative pathologies pointing toward the significance of IGH locus in oncogenic progression. Significantly, in the majority of B-cell neoplasms that carry an IGH;BCL3 rearrangement, it is a sole translocation involving an IGH locus. CASE PRESENTATION: We report a patient who, in addition to trisomy 12, carried a rare double-hit translocation characterized by the IGH;BCL3 translocation and an additional clonal IGH;BCL2 translocation involving IGH and another proto-oncogene BCL2, t(14;18)(q32;q21), commonly found in follicular lymphoma. Further single nucleotide polymorphism (SNP) array-based analysis detected a duplication of the 58.8 kb region at 19q13.32 adjacent to the BCL3 translocation junction on chromosome 19q13. Interestingly, the duplicated region contained ERCC2 gene, which encodes a DNA excision repair protein involved in the cancer-prone syndrome, xeroderma pigmentosum. CONCLUSIONS: Taken together our findings indicate the existence of double-translocation driven oncogenic events involving both IGH loci and proto-oncogenes BCL2 and BCL3. Importantly, the IGH;BCL3 translocation was characterized by the duplication of the genomic region adjacent to BCL3, containing a major DNA repair factor, ERCC2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13039-015-0203-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4696310
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46963102015-12-31 Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia Alpatov, Roman Carstens, Billie Harding, Kimberly Jarrett, Carolyn Balakhani, Sudabeh Lincoln, Jessica Brzeskiewicz, Peter Guo, Yu Ohene-Mobley, Alex LeRoux, Jamie McDaniel, Veronica Meltesen, Lynne Minka, Diane Patel, Mahendra Manavi, Cyrus Swisshelm, Karen Mol Cytogenet Case Report BACKGROUND: Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disease characterized by multiple recurring clonal cytogenetic anomalies and is the most common leukemia in adults. Chromosomal abnormalities associated with CLL include trisomy 12 and IGH;BCL3 rearrangement [t(14;19)(q32;q13)] that juxtaposes a proto-oncogenic gene BCL3 and an immunoglobulin heavy chain, a translocation that may be associated with shorter survival. In addition to the IGH;BCL3 rearrangement, other translocations involving 14q32 locus are involved in various lymphoproliferative pathologies pointing toward the significance of IGH locus in oncogenic progression. Significantly, in the majority of B-cell neoplasms that carry an IGH;BCL3 rearrangement, it is a sole translocation involving an IGH locus. CASE PRESENTATION: We report a patient who, in addition to trisomy 12, carried a rare double-hit translocation characterized by the IGH;BCL3 translocation and an additional clonal IGH;BCL2 translocation involving IGH and another proto-oncogene BCL2, t(14;18)(q32;q21), commonly found in follicular lymphoma. Further single nucleotide polymorphism (SNP) array-based analysis detected a duplication of the 58.8 kb region at 19q13.32 adjacent to the BCL3 translocation junction on chromosome 19q13. Interestingly, the duplicated region contained ERCC2 gene, which encodes a DNA excision repair protein involved in the cancer-prone syndrome, xeroderma pigmentosum. CONCLUSIONS: Taken together our findings indicate the existence of double-translocation driven oncogenic events involving both IGH loci and proto-oncogenes BCL2 and BCL3. Importantly, the IGH;BCL3 translocation was characterized by the duplication of the genomic region adjacent to BCL3, containing a major DNA repair factor, ERCC2. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13039-015-0203-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-30 /pmc/articles/PMC4696310/ /pubmed/26719766 http://dx.doi.org/10.1186/s13039-015-0203-y Text en © Alpatov et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Alpatov, Roman
Carstens, Billie
Harding, Kimberly
Jarrett, Carolyn
Balakhani, Sudabeh
Lincoln, Jessica
Brzeskiewicz, Peter
Guo, Yu
Ohene-Mobley, Alex
LeRoux, Jamie
McDaniel, Veronica
Meltesen, Lynne
Minka, Diane
Patel, Mahendra
Manavi, Cyrus
Swisshelm, Karen
Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title_full Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title_fullStr Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title_full_unstemmed Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title_short Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia
title_sort rare double-hit with two translocations involving igh both, with bcl2 and bcl3, in a monoclonal b-cell lymphoma/leukemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696310/
https://www.ncbi.nlm.nih.gov/pubmed/26719766
http://dx.doi.org/10.1186/s13039-015-0203-y
work_keys_str_mv AT alpatovroman raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT carstensbillie raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT hardingkimberly raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT jarrettcarolyn raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT balakhanisudabeh raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT lincolnjessica raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT brzeskiewiczpeter raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT guoyu raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT ohenemobleyalex raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT lerouxjamie raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT mcdanielveronica raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT meltesenlynne raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT minkadiane raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT patelmahendra raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT manavicyrus raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia
AT swisshelmkaren raredoublehitwithtwotranslocationsinvolvingighbothwithbcl2andbcl3inamonoclonalbcelllymphomaleukemia